Cannabis Investors: Forget THC! The CBD Market Could Be Where the Puck Is Headed Next!

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) has incredible CBD and hemp assets that the general public may be severely discounting at this juncture.

| More on:
lush marijuana plants

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Recreational cannabis is now legalized from coast to coast, but there still exists a taboo on the drug in spite of its promising therapeutic potential.

The THC market expectations are “too high”

When most folks hear about cannabis, the first thing that comes to mind is “getting stoned.”

The intoxicating effects tetrahydrocannabinol (THC), the main psychoactive compound in cannabis, renders a user couch-locked (like a stone), giving them the munchies, temporarily impairing their cognitive abilities, and potentially leaving them with a brain fog (a marijuana hangover) for hours, even days after THC’s effect on the brain has worn off.

As you’d imagine, nationwide legalization of cannabis isn’t every Canadian’s cup of tea, although I’m sure many non-users are now more willing to try the drug for the first time now that it’s completely legal at the federal level.

The main reason THC may never take off, though, is the fact that its psychoactive effects aren’t at all desirable to a vast majority of individuals because it “kills productivity,” as Elon Musk once alluded to after smoking a joint on with Joe Rogan on his podcast.

Smoking THC-rich cannabis can be a real time sink, and if you’re a busy person with a list of things to do, there’s simply no room in your weekly schedule for marijuana. And for those with ample amounts of “down time,” not everybody is a fan of the feeling of getting high, as it can bring forth some negative feelings including anxiety or paranoia.

Cannabis has many promising therapeutic effects, but for most, the psychoactive effects of THC are a deal breaker.

The CBD market could grow much faster than we expect

Consider cannabidiol (CBD), another cannabis constituent that contains many of the same therapeutic properties (reducing inflammation, aiding in sleep, etc.) that THC has, the only difference being CBD doesn’t get you high. Thus, CBD isn’t a productivity killer like THC is, which is why I think the CBD market may have way more long-term potential than the THC market.

While most pot investors are focused on THC-dominant cannabis plant components like bud or flower, the real opportunity may lie within good, old-fashioned hemp, which has a higher concentration of CBD relative to THC.

The cannabis market isn’t just about catering to the folks who want to smoke bud or eat pot brownies. Only a small percentage of the population is interested in doing this on a consistent basis. The real opportunity, I believe, lies within the CBD scene, an overlooked market that’s projected to grow to US$2.1 billion by 2020 according to the Hemp Business Journal.

As non-intoxicating consumer packaged CBD edibles, vapeables, and smokables become more prevalent over the next three years, I suspect the growth experienced by the CBD market could exceed even the most bullish of projections.

CBD is the perfect disruptor compound, so investors should strongly consider beefing up their weed portfolios with a play that’ll give them a greater amount of exposure to hemp and the CBD market. Think Aurora Cannabis (TSX:ACB)(NYSE:ACB), which has been quietly backing up the truck on quality hemp assets over the past few years, leading me to believe the company is doubling down on CBD and other cannabinoids that go beyond THC.

Foolish takeaway

The way I see it, CBD is the answer for the pill-popping, sleep-deprived population who’s living with chronic pain and/or anxiety. The undesired side effects of CBD are far subtler than THC or any other alternative drug that’s out there, making it the most suitable substance for the general public who may not be interested in getting higher than a kite.

Stay hungry. Stay Foolish.

Should you invest $1,000 in Ishares S&p/tsx Canadian Dividend Aristocrats Index Etf right now?

Before you buy stock in Ishares S&p/tsx Canadian Dividend Aristocrats Index Etf, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Ishares S&p/tsx Canadian Dividend Aristocrats Index Etf wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,058.57!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 38 percentage points since 2013*.

See the Top Stocks * Returns as of 2/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Investing

dividend growth for passive income
Stock Market

5 Cheap Canadian Stocks to Buy Right Now With $5,000

Here's why investing in these five cheap TSX stocks can help Canadians deliver outsized gains in 2025 and beyond.

Read more »

dividends grow over time
Dividend Stocks

Income Investors: These Canadian Dividend All-Stars Are Raising Payouts Again

Long-term income investors can consider these Canadian dividend all-stars that are trading at good valuations.

Read more »

ways to boost income
Stocks for Beginners

Best Canadian Stocks to Buy With $7,000 Right Now

Got $7,000 to invest in your 2025 TFSA contribution? Here are three diverse Canadian stocks to add right now.

Read more »

Paper Canadian currency of various denominations
Dividend Stocks

Here’s How Many Shares of ZMI You Should Own to Get $500 in Monthly Dividends

This BMO monthly income ETF is diversified and easy to understand.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Wednesday, March 19

The U.S. Federal Reserve’s interest rate decision, press conference, and economic projections will remain on TSX investors’ radar today.

Read more »

Rocket lift off through the clouds
Tech Stocks

Plummet or Opportunity? Why This TSX Stock Could Skyrocket From Here

This TSX stock may be down for now, but don't count it out as a solid long-term growth opportunity.

Read more »

dividends can compound over time
Dividend Stocks

Tariff Risks Are Rising: Here’s How to Stay Ahead as an Investor

Are you worried about tariffs? Worry no more and protect yourself with these three stocks offering protection.

Read more »

investor looks at volatility chart
Dividend Stocks

Market Correction: 3 Canadian Stocks to Buy Before Prices Rebound

These three Canadian stocks certainly offer a lot to investors, such as stability and value, but growth is definitely in…

Read more »